Skip to main content
. 2022 Aug 30;17(3):174–182. doi: 10.5469/neuroint.2022.00199

Table 3.

Literature review of embolization of cerebral AVM with PHIL and Squid liquid embolic agents

Study Patient (n) Agent Complete obliteration rate Complication rate
Sirakov et al. [21] (2019) 27 PHIL 25 52% 22.2%
Koçer et al. [5] (2016) 3 PHIL 0% (mean obliteration 80%) 0%
Akmangit et al. [7] (2014) 16 Squid 18 37.5% 12.5% (intracranial hemorrhage)
Squid 12
Samaniego et al. [6] (2016) 5 PHIL 60% 0%

AVM, arteriovenous malformation; PHIL, precipitating hydrophobic injectable liquid.